Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Do we need randomised trials to evaluate diagnostic procedures? For.

Literature DB >> 14647984

Do we need randomised trials to evaluate diagnostic procedures? For.

H Van Tinteren¹, O S Hoekstra, M Boers.

Abstract

Mesh：

Year: 2003 PMID： 14647984 DOI： 10.1007/s00259-003-1384-x

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

× No keyword cloud information.

20 in total

Review 1. The role of randomization in clinical studies: myths and beliefs.

Authors: U Abel; A Koch
Journal: J Clin Epidemiol Date: 1999-06 Impact factor: 6.437

2. Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?

Authors: Liselotte Højgaard
Journal: Eur J Nucl Med Mol Imaging Date: 2003-05 Impact factor: 9.236

3. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.

Authors: H C Steinert; M Hauser; F Allemann; H Engel; T Berthold; G K von Schulthess; W Weder
Journal: Radiology Date: 1997-02 Impact factor: 11.105

Review 4. Evaluating and comparing imaging techniques: a review and classification of study designs.

Authors: L S Freedman
Journal: Br J Radiol Date: 1987-11 Impact factor: 3.039

5. Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

Authors: R M Pieterman; J W van Putten; J J Meuzelaar; E L Mooyaart; W Vaalburg; G H Koëter; V Fidler; J Pruim; H J Groen
Journal: N Engl J Med Date: 2000-07-27 Impact factor: 91.245

6. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

Authors: Harm van Tinteren; Otto S Hoekstra; Egbert F Smit; Jan H A M van den Bergh; Ad J M Schreurs; Roland A L M Stallaert; Piet C M van Velthoven; Emile F I Comans; Fred W Diepenhorst; Paul Verboom; Johan C van Mourik; Pieter E Postmus; Maarten Boers; Gerrit J J Teule
Journal: Lancet Date: 2002-04-20 Impact factor: 79.321

Do we need randomised trials to evaluate diagnostic procedures? For.

Review 1. The role of randomization in clinical studies: myths and beliefs.

2. Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?

3. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.

Review 4. Evaluating and comparing imaging techniques: a review and classification of study designs.

5. Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

6. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

7. Investigation for mediastinal disease in patients with apparently operable lung cancer. Canadian Lung Oncology Group.

8. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

9. The noninvasive staging of non-small cell lung cancer: the guidelines.

Review 10. Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

1. PET/CT in Oncology: Current Status and Perspectives.